Biocon on Friday reported a 23.01% fall in its consolidated net profit to ₹195.4 crore for the second quarter ended September 30, mainly on account of higher expenses. The buzz around
Tag "Covid Vaccine"
The partners haven’t had to stop their late-stage study over safety concerns, BioNTech Chief Executive Officer Ugur Sahin said Side effects that have emerged in a large late-stage trial of
Earlier this month, Johnson & Johnson joined the short list of vaccine makers that have moved an experimental coronavirus shot into late-stage human studies in the US Johnson & Johnson
The Sechenov First Moscow State Medical University began clinical trials of the vaccine produced by Russia’s Gamalei Institute of Epidemiology and Microbiology on June 18 The clinical trials of the